Laboratories of all sizes and disciplines can now empower their testing with the proven performance of the cobas® 6800 System.
As healthcare faces increasing labor shortages, evolving regulations, and new players entering the market, laboratories should look for sustainable solutions that can ensure their long-term success.
The cobas® 6800 System is a fully automated solution with high-throughput, that can drive laboratory efficiency in a number of ways.
As the first high-throughput, fully integrated laboratory automation system with a broad menu, the cobas® 6800 System allows you to experience real-time polymerase chain reaction (PCR) technology like never before.
*May vary based on workflow demands.
The cobas® 6800 System is designed to meet the ever-changing needs of your laboratory and your organization. The broad on-demand assay menu delivers reliable results across a wide range of applications, making test consolidation easy and effective.
* In development
† Not available in the US
‡ Self-sampling in development
§ cobas omni Utility Channel CE-IVD
¶ cobas omni Utility Channel Primer/Probe Set
# cobas® Plasma Separation Card
∥ Emergency Use Authorization (EUA) CE-IVD
The cobas® 6800 System can help you meet the growing needs of your lab with highly efficient workflows, from sample processing to result interpretation.
Deliver trusted, reproducible results while rapidly completing your daily testing requirements. Run up to 96 results in about 3 hours* and up to 864 results in an 8 hour shift.*
Since 2014, more than 800 instruments have been installed on five continents, delivering consolidated testing and increased efficiency for laboratories.
Transform “walk-away” time into “work-away” time. Minimal and intuitive interactions reduce the potential for human error and free-up technicians for other tasks.
Pre-analytical automation solutions can further reduce manual touchpoints, resulting in a true “samples in, results out” workflow. Additional post-analytics units facilitate fully-automated sample archiving and retrieval for add-on testing.
*May vary based on workflow demands
Meet your needs today and in the future with simplified workflows plus universal processes, consumables, and reagents. The cobas® 6800 System requires no sorting or batching of samples, no reagent preparation, and no manual set up of runs.
Today, Sabin laboratory is well-prepared to address the current and future needs of their customers. Their recent integration of the cobas® 6800 System improved overall testing flexibility, automation, and efficiency.
Only Roche delivers proven integration at an unsurpassed level. The cobas® 6800 System can be physically and virtually integrated with pre- and post-analytic solutions, as well as across disciplines—including serum work area (SWA), urinalysis, and hematology using cobas® connection modules (CCM).
Our solutions are designed to work together as one, and these flexible connectivity solutions realize that vision.
Experience integration to the next power with comprehensive management tool designed to keep you in the driver seat.
The future of diagnostics connectivity is here. Prepare your laboratory today for a more sustainable tomorrow.
Powered by Nobel-prize winning PCR, Roche’s leading diagnostic solutions continue to transform molecular testing. Roche introduced the world to PCR and is committed to driving laboratory innovation into the future.
Roche Healthcare Consulting gives you access to our world-class service team comprised of more than 2,000 technical and field experts in more than 70 countries. Partnering with Roche connects your laboratory to unparalleled diagnostic expertise and puts the future of molecular testing is in our collective hands.
IVD
Access package inserts through your country’s Roche Diagnostics Website.
Unparalleled performance with minimal operator interaction revolutionises the future of high-throughput applications.
The cobas omni Utility Channel enables a broader testing menu by consolidating open channel assays with Roche IVD assays on a single platform. Open channel assays may include IVD assays, as well as routine lab developed tests (LDTs).
